Who Paid My Doc
A Phase 2B Multicenter, Randomized, Open-Label Study Comparing the Eff
Research payments
$2,875,342
Through program year 2025, $2,875,342 in research payments was reported against A Phase 2B Multicenter, Randomized, Open-Label Study Comparing the Eff, across 658 payments, paid by ViiV Healthcare Company.
- Paid by
- ViiV Healthcare Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,594,589 | 613 |
| 2024 | Research | $280,753 | 45 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ogechika Alozie El Paso, TX Named on 60 payments
- Linda Gorgos San Francisco, CA Named on 57 payments
- William Towner Los Angeles, CA Named on 30 payments
- Michael Frank Milwaukee, WI Named on 28 payments
- Javier Morales Ramirez Santurce, PR Named on 28 payments
- Zachary Henry Fort Lauderdale, FL Named on 26 payments
- Anthony Mills West Hollywood, CA Named on 26 payments
- Cornelius Van Dam Greensboro, NC Named on 25 payments
- Princy Kumar Washington, DC Named on 25 payments
- Charlotte-Paige Rolle Orlando, FL Named on 22 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.